Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-07-15

Clinical Trial Update: Empagliflozin vs Metformin in PCOS [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial comparing empagliflozin to metformin in polycystic ovary syndrome has completed phases 2 and 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Empagliflozin (empagliflozin)
  • metformin (metformin)

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Polycystic Ovary Syndrome | Phase 2, Phase 3 | Status: COMPLETED